Skip to main content

GI Connect

Children's Mercy at NASPGHAN 2019

With a robust schedule of presentations, there are plenty of opportunities for us to connect with you at NASPGHAN. Join us for any of our sessions or reach out to have conversations.

Whether you have questions specific to these presentations or our multispecialty clinics, we’re open to sharing information as we work together to care for children with challenging issues or rare syndromes.

Thursday, October 17
5-7 p.m.

  • Morrow R, Shakhnovich V. Methotrexate polyglutamates as biomarkers of treatment response in IBD vs. JIA.
  • Kaul I, Chumpitazi B, Colombo J, Schurman J, Bagherian A, Shulman R, Friesen C. Evaluation of pediatric Rome IV criteria and diagnostic testing for functional gastrointestinal disorders.
  • Ibrahimi N, Goyal A. Appendiceal carcinoid, a rare mimicker of Crohn’s disease.
  • El Tawil, D., Low Kapalu, C.M., & Attard, T. Differences and health care disparities in hospitalizations for management of constipation in children with and without autism spectrum disorder.
  • Daniel J. Delta bilirubin in acute liver failure. A lesser known bilirubin fraction and its impact on interpretation of single pass albumin dialysis (SPAD) efficacy.
  • Rosen JM, Low Kapalu C, Cocjin J. Impedance-manometry correlates with symptom experience in belch reflex dysfunction.
  • Morrow R, Srivistava T, Cully B, Goyal A. Fragility fractures in children with inflammatory bowel disease: X-ray and DEXA can be misleading.

Friday, October 18
7-8 a.m.

Low Kapalu, C.M. & Belkind-Gerson, J. (2019, Oct). Fecal incontinence and functional constipation: A behavioral masterclass.

Friday, October 18
2:30-4 p.m.

  • Attard T. Management of hereditary polyposis in children (FAP, PJS, JPS). NASPGHAN-ESPGHAN Societal Papers Session.
  • Shakhnovich, V. Impact of obesity in changes in physiology and systemic drug exposure to proton pump inhibitors. Hot Topics 2: Novel approaches and challenges in gastroenterology.

Friday, October 18
12-2 p.m.

  • Jausurawong T, Shakhnovich V. Implications of B-cell dysregulation in pediatric duodenal Crohn’s disease.
  • Hijaz NM, Attard, TM, Colombo JM, Mardis NJ, Friesen CA. Comparison of the use of wireless capsule endoscopy with magnetic resonance enterography in children with inflammatory bowel disease.
  • Garzia J, Attard T, Rosen JM. Colonic hydrotherapy prior to colonoscopy when oral bowel preparation is inadequate- A proof of concept study.
  • Rosen JM, Waller M. Assessment of telemedicine perception as a guide for program expansion in pediatric gastroenterology.

Saturday, October 19
10:30 a.m. – 12 p.m.

  • Goyal A, moderator. Treating the entire IBD patient.

Saturday, October 19
12-2 p.m.

  • Shakhnovich V. Variability in liver composition in children participating in pharmacokinetic studies of proton pump inhibitors.
  • Rosen JM, Olthof S, Low Kapalu C. Inability to burp as a primary gastrointestinal symptom in children.
  • Low Kapalu C, Olthof S, Rosen JM. R/NoBurp- Exploring the process of patient initiated social media research in disorder discovery.
  • Olthof S, Low Kapalu C, Rosen JM. Belch reflex dysfunction- a patient initiated international survey of the inability to burp.
  • Plevinsky JM, Maddux M, Greenley R. Perceived impact of pediatric inflammatory bowel diseases on academics, college plans, and college adjustment.